Zobrazeno 1 - 10
of 14
pro vyhledávání: '"B L, Moskovitz"'
Publikováno v:
European journal of dermatology : EJD. 9(7)
Over the past 10 years, itraconazole has been used to treat more than 34 million patients worldwide. We present a review of the safety of various continuous itraconazole schedules used in the treatment of dermatomycosis and onychomycosis. Data from c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::af163630ac2b9e04b4b094465303e73e
https://pubmed.ncbi.nlm.nih.gov/10523732
https://pubmed.ncbi.nlm.nih.gov/10523732
Autor:
M S, Saag, G A, Cloud, J R, Graybill, J D, Sobel, C U, Tuazon, P C, Johnson, W J, Fessel, B L, Moskovitz, B, Wiesinger, D, Cosmatos, L, Riser, C, Thomas, R, Hafner, W E, Dismukes
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 28(2)
This study was designed to compare the effectiveness of fluconazole vs. itraconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. HIV-infected patients who had been successfully treated (achieved negative culture of CSF) for a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::643cedb431207d4aeafc0e3b24042894
https://pubmed.ncbi.nlm.nih.gov/10064247
https://pubmed.ncbi.nlm.nih.gov/10064247
Autor:
J A, Barone, B L, Moskovitz, J, Guarnieri, A E, Hassell, J L, Colaizzi, R H, Bierman, L, Jessen
Publikováno v:
Pharmacotherapy. 18(2)
To evaluate the effect of food on the bioavailability of itraconazole (ITR) hydroxypropyl-beta-cyclodextrin (HP-beta-CD) solution under multiple-dose to steady-state conditions, and to determine the pharmacokinetics of ITR solution at steady state.Op
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::979e671e01ba49f68fa5e55c92bae1c4
https://pubmed.ncbi.nlm.nih.gov/9545149
https://pubmed.ncbi.nlm.nih.gov/9545149
Autor:
C M, van der Horst, M S, Saag, G A, Cloud, R J, Hamill, J R, Graybill, J D, Sobel, P C, Johnson, C U, Tuazon, T, Kerkering, B L, Moskovitz, W G, Powderly, W E, Dismukes
Publikováno v:
The New England journal of medicine. 337(1)
Treatment with low-dose amphotericin B (0.4 mg per kilogram of body weight per day) or oral azole therapy in patients with the acquired immunodeficiency syndrome (AIDS) and cryptococcal meningitis has been associated with high mortality and low rates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cdf9b8a0de1b05c26334defff09c1228
https://pubmed.ncbi.nlm.nih.gov/9380128
https://pubmed.ncbi.nlm.nih.gov/9380128
Autor:
B L Moskovitz, M C Gaffar, J G Koh, John L. Colaizzi, V. Van de Velde, Witold Mechlinski, Joseph A. Barone, K A Swanson, Robert H. Bierman
The influence of food on itraconazole pharmacokinetics was evaluated for 27 healthy male volunteers in a single-dose (200 mg) crossover study with capsules containing itraconazole-coated sugar spheres. This study was followed by a study of the steady
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50cee0548328ff37e899dcb55ffe8491
https://europepmc.org/articles/PMC187759/
https://europepmc.org/articles/PMC187759/
Autor:
B L Moskovitz
Publikováno v:
Antimicrobial Agents and Chemotherapy. 32:1300-1303
An open-label, multicenter clinical trial assessed the tolerance of HPA-23 (ammonium-21-tungsto-9-antimoniate) in patients with acquired immune deficiency syndrome. Sixty-nine patients were sequentially assigned to receive 0.25, 0.5, 1.0, or 2.0 mg o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ceaf81f7b1fde37d3328fd2d3c9f99d
https://doi.org/10.1128/aac.32.9.1300
https://doi.org/10.1128/aac.32.9.1300
Publikováno v:
Journal of Antimicrobial Chemotherapy. 22:189-191
Spiramycin, 3 g daily, was used to treat immunocompromised patients with chronic diarrhoea due to Cryptosporidium. Most patients treated had acquired immune deficiency syndrome. Among 37 patients evaluated, 28 had a favourable response, defined as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aea127b7ca30cd8801db7e721a6e7154
https://doi.org/10.1093/jac/22.supplement_b.189
https://doi.org/10.1093/jac/22.supplement_b.189
Publikováno v:
The Journal of antimicrobial chemotherapy. 22
Spiramycin, 3 g daily, was used to treat immunocompromised patients with chronic diarrhoea due to Cryptosporidium. Most patients treated had acquired immune deficiency syndrome. Among 37 patients evaluated, 28 had a favourable response, defined as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3180eae073914b5239012cf7aabfda5b
https://pubmed.ncbi.nlm.nih.gov/3182442
https://pubmed.ncbi.nlm.nih.gov/3182442
Publikováno v:
Archives of internal medicine. 142(1)
Meningovascular syphilis developed in a patient two years after the treatment of primary syphilis with a single intramuscular injection of 2.4 million units of penicillin G benzathine as recommended by the Centers for Disease Control. Although it cou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dddec6e366ddfea9080c93efe890434d
https://pubmed.ncbi.nlm.nih.gov/7053714
https://pubmed.ncbi.nlm.nih.gov/7053714
Autor:
B L, Moskovitz
Publikováno v:
The American journal of medicine. 77(4C)
The clinical safety of ceftriaxone administered at various doses for time periods ranging from a single injection to up to six weeks was evaluated in 2,640 patients treated in 153 individual studies. The incidence of clinical adverse effects was grea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6861e4d1e62e086a81169587c83e7b3a
https://pubmed.ncbi.nlm.nih.gov/6093526
https://pubmed.ncbi.nlm.nih.gov/6093526